» Articles » PMID: 3926889

Regulation of IFN-gamma Induction in Human Peripheral Blood Cells by Exogenous and Endogenously Produced Interleukin 2

Overview
Journal J Immunol
Date 1985 Sep 1
PMID 3926889
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Interferon (IFN)-gamma production, stimulated by the addition of exogenous interleukin (IL) 2, T cell mitogens, or tuberculin purified protein derivative (PPD) was studied in cultures of separated human mononuclear cells or unseparated peripheral blood leukocytes (PBL). IFN-gamma was induced by the addition of IL 2 to cultures of otherwise unstimulated cells. The minimal concentration of exogenous IL 2 required to cause a reproducible stimulation of IFN-gamma was about 10 U/ml, i.e., approximately 50 times the minimal concentration required to stimulate proliferation in an IL 2-dependent murine cytotoxic T cell line. Approximately 500 to 1000 IL 2 U/ml were required to produce maximal stimulation of IFN-gamma production in otherwise unstimulated cultures. Monoclonal antibody anti-Tac, specific for an epitope associated with the IL 2 receptor (IL 2 R), inhibited IFN-gamma induction by exogenous IL 2 less strongly than induction by phytohemagglutinin (PHA) or concanavalin A (Con A). The highest degree of inhibition was exerted by anti-Tac on IFN-gamma production stimulated with PPD. Stimulation of IFN-gamma induction by exogenous IL 2 and the inhibitory action of anti-Tac on IFN-gamma production were also seen in cultures of irradiated (2000 R) cells. Treatment of cells with subinducing doses of Con A or phorbol myristate acetate increased IFN-gamma induction by exogenous IL 2. Taken together, the data suggest that endogenously generated IL 2 is a major mediator of IFN-gamma induction in PBL cultures stimulated with antigens or T cell mitogens.

Citing Articles

Efficacy and antitumor activity of a mutant type of interleukin 2.

Dehghan R, Beig Parikhani A, Zeinali S, Shokrgozar M, Amanzadeh A, Ajdary S Sci Rep. 2022; 12(1):5376.

PMID: 35354847 PMC: 8968711. DOI: 10.1038/s41598-022-09278-7.


Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.

Kulling P, Olson K, Hamele C, Toro M, Tan S, Feith D PLoS One. 2018; 13(2):e0193429.

PMID: 29474442 PMC: 5825082. DOI: 10.1371/journal.pone.0193429.


Loci controlling lymphocyte production of interferon c after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibility.

Lipoldova M, Havelkova H, Badalova J, Vojtiskova J, Quan L, Krulova M Cancer Immunol Immunother. 2009; 59(2):203-13.

PMID: 19655140 PMC: 2776939. DOI: 10.1007/s00262-009-0739-y.


In vitro interleukin 4 and interferon-gamma production by mononuclear cells from atopic dermatitis patients.

Well S, Diel F Mediators Inflamm. 1993; 2(6):411-5.

PMID: 18475556 PMC: 2365435. DOI: 10.1155/S0962935193000584.


HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3-dioxygenase activity.

Logan G, Smyth C, Earl J, Zaikina I, Rowe P, Smythe J Immunology. 2002; 105(4):478-87.

PMID: 11985668 PMC: 1782674. DOI: 10.1046/j.1365-2567.2002.01390.x.